The agreement with the dutch regulation for reimbursement of anti-TNFα for patients with rheumatoid arthritis in daily clinical practice discussed

被引：0
|
作者：
Kievit, W. [1 ]
Adang, E. M. [1 ]
Franssen, J. [1 ]
Kuper, I. H. [2 ]
van de Laar, M. A. F. J. [2 ]
de Rooij, D. R. A. M. [3 ]
De Gendt, C. M. A. [4 ]
Janssens, T. L. [5 ]
van Ooijen, P. C. M. [6 ]
Brus, H. L. M. [7 ]
van Riel, P. L. C. M. [1 ]
机构：
[1] Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen, Netherlands
[2] Med Spectrum Twente, Enschede, Netherlands
[3] Sint Maartensklin, Nijmegen, Netherlands
[4] Rijnstate Hosp, Arnhem, Netherlands
[5] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[6] Jeroen Bosch Hosp, Den Bosch, Netherlands
[7] Tweesteden Hosp, Tilburg, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：264 / 264
页数：1
相关论文
共 50 条
  • [21] The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice
    Kievit, W.
    Fransen, J.
    Oerlemans, A. J. M.
    Kuper, H. H.
    van der Laar, M. A. F. J.
    de Rooij, D. J. R. A. M.
    De Gendt, C. M. A.
    Ronday, K. H.
    Jansen, T. L.
    van Oijen, P. C. M.
    Brus, H. L. M.
    Adang, E. M.
    van Riel, P. L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (11) : 1473 - 1478
  • [22] Predicting response to anti-TNF treatment in rheumatoid arthritis patients
    Atzeni, Fabiola
    Antivalle, Marco
    Pallavicini, Francesca Bobbio
    Caporali, Roberto
    Bazzani, Chiara
    Gorla, Roberto
    Favalli, Ennio Giulio
    Marchesoni, Antonio
    Sarzi-Puttini, Piercarlo
    AUTOIMMUNITY REVIEWS, 2009, 8 (05) : 431 - 437
  • [23] THE INFLUENCE OF ANTI-TNF DRUGS ON OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Ruci, D.
    Ruci, V.
    Jordhani, M.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S122 - S122
  • [24] Polyneuropathy associated with anti-TNF therapy in patients with rheumatoid arthritis
    Jurand, J
    Zochodne, D
    Barr, S
    Voll, C
    Martin, L
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1405 - 1405
  • [25] Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFα
    Eriksson, C
    Engstrand, S
    Sundqvist, KG
    Rantapää-Dahlqvist, S
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (03) : 403 - 407
  • [26] Clinical outcomes in patients after one or multiple anti-TNF therapies in rheumatoid arthritis
    Glass, Roberta J.
    Shadick, Nancy A.
    Cui, Jing
    Maher, Nancy
    Weinblatt, Michael
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S526 - S526
  • [27] ASSOCIATION OF THE MICA POLYMORPHISM WITH CLINICAL RESPONSE TO ANTI-TNF THERAPY IN RHEUMATOID ARTHRITIS PATIENTS
    Iwaszko, Milena
    Swierkot, Jerzy
    Kolossa, Katarzyna
    Jeka, Slawomir
    Wiland, Piotr
    Bogunia-Kubik, Katarzyna
    HLA, 2017, 89 (06) : 466 - 466
  • [28] Anti-TNF alpha and pseudoseptic arthritis in rheumatoid arthritis
    Vega, AJL
    Gonzalez, D
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 206 - 206
  • [29] The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
    de Punder, Yvonne M. R.
    Fransen, Jaap
    Kievit, Wietske
    Houtman, Pieternella M.
    Visser, Henk
    van de Laar, Mart A. F. J.
    van Riel, Piet L. C. M.
    RHEUMATOLOGY, 2012, 51 (09) : 1610 - 1617
  • [30] Clinical effectiveness of anti-TNF, non-anti-TNF and tofacitinib in the treatment of rheumatoid arthritis
    Oliveira, Gerusa
    Morgado, Marina
    Brandao, Natalia
    Barreto, Jessica
    Acurcio, Francisco A.
    Guerra Junior, Augusto
    Alvares-Teodoro, Juliana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 170 - 170
12345